Percutaneous Antegrade Ureteric Stenting in Patients with Failed Retrograde Approach: A Prospective Study
Authors
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Aim: To evaluate procedural success rate and complications in percutaneous antegrade ureteric stenting. Materials and Methods: A total of 21 patients (12 males, 9 females, mean age 48 years) with obstructive hydronephrosis, of benign or malignant origin with failure of retrograde stent placement were enrolled in our study. Primary stenting was attempted in 10(48%) patients and rest of the patients was subjected to conventional two stage procedure. End point assessments were technical and clinical success rate, procedural complications. Results: A total of 26 procedures in 21 patients were done in the study: 16 procedures in 11 patients were in the secondary group and 10 procedures in 10 patients were in the primary group. Our technical success rates were 87% and 80% in secondary and primary groups, respectively. Overall technical and clinical success rate in our study was 84.6% and 85% respectively. Five out of 21 patients developed (23.8%) minor complications; however there were no major complications in our study. Conclusion: Percutaneous antegrade ureteral stent placement is a safe and effective method for manage-ment of ureteric obstructions due to both malignant and benign causes when the retrograde approach has failed and when the retrograde approach is difficult.
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2025 Dr Ajaz Mohi Ud Din, Dr Syed Sajad Ahmad, Dr Huda Amin, Dr Asma Gulzar, Dr Tavseef Ahmad Tali
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons License All articles published in Annals of Medicine and Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License.
Dr Syed Sajad Ahmad, Department of Radiology, Government Medical College Baramulla, J&K, India.
Department of Radiology, Government Medical College Baramulla, J&K, India.
Dr Huda Amin, Department of Gynaecology & Obstetrics, Ramzaan Hospital, Gogji Bagh, Srinagar, J&K, India.
Department of Gynaecology & Obstetrics, Ramzaan Hospital, Gogji Bagh, Srinagar, J&K, India.
Dr Asma Gulzar, Department of Radiology, Government Medical College Handwara, J&K, India.
Department of Radiology, Government Medical College Handwara, J&K, India.
Dr Tavseef Ahmad Tali, Department of Radiation Oncology, Government Medical College Baramulla, J&K, India.
Department of Radiation Oncology, Government Medical College Baramulla, J&K, India.
[1] Uthappa MC, Cowan NC. Retrograde or antegrade double pigtail stent placement for malignant ureteric obstruction? Clinical Radiology.2005 May 1;60(5):608-612.
[2] Chye RW, Lickiss JN. Palliative care in bilateral malignant ureteric obstruction. Annals of the Academy of Medicine, Singapore.1994 Mar;23(2): 197-203.
[3] Gasparini M, Carroll P, Stoller M. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction. Urology 1991 Nov 1;38(5):408-412.
[4] Harding J R. Percutaneous antegrade ureteric stent insertion in malignant disease. J R Soc. Med. 1993 Sep; 86: 511-513.
[5] Venyo A, Bakir E. Antegrade Ureteric Stenting Prospective Experience in Managing 30 Patients; Indications; Complications and Outcome, Webmed Central UROLOGY. 2011; 2(1): WMC001442.
[6] Wilson JR, Urwin GH, Stower MJ. The role of percutaneous nephrostomy in malignant ureteric obstruction. Annals of the Royal College of Surgeons of England. 2005 Jan;87(1):21–24.
[7] Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 1967; 97:840–844.
[8] Seymour H, Patel U. Ureteric stenting: current status. Semin Intervent Radiol 2000; 17:351–365.
[9] Mitty HA. Stenting of the ureter. Clinical urography. 2nd ed. Philadelphia, Pa: Saunders. 2000: 3186-3205.
[10] Van Arsdalen KN, Pollack HM, Wein AJ. Ureteral stenting. SeminUrol 1984; 2:180–186.
[11] Chen ASC, Saltzman B. Stent use with extracorporeal shock wave lithotripsy. J Endourol 1993; 7:155-162.
[12] Denstedt JD, Reid G, Sofer M. Advances in ureteral stent technology. World J Urol 2000; 18:237-242.
[13] Watson G. Problems with double-J stents and nephrostomy tubes. J Endourol 1997; 11:413-417.
[14] Hood CG, Dyer RB, Zagoria RJ. Complications of ureteral stenting. Appl Radiol 1990; 19:35-42.
[15] Hausegger KA, Portugaller HR. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications. Eur Radiol. 2006;16:2016–30.
[16] Watson GM, Patel U. Primary antegrade ureteric stenting: prospective experience and cost-effectiveness analysis in 50 ureters. Clinical radiology. 2001 Jul 1;56(7):568–74.
[17] Chitale S, Raja V, Hussain N, et al. One-stage tubeless antegrade ureteric stenting: a safe and cost-effective option? Ann R Coll SurgEngl 2010 Apr; 92(3): 218–224.
[18] Pabon-Ramos WM, Dariushnia SR, Walker TG, et al. Society of Interventional Radiology Stan-dards of Practice Committee. Quality Improvement Guidelines for Percutaneous Nephrostomy. J VascIntervRadiol 2016; 27:410–414.
[19] Kahriman G, Özcan N, Doğan A, et al. Percutaneous antegrade ureteral stent placement: single center experience. Diagn IntervRadiol 2019 Mar; 25(2):127–133.
[20] Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: experience at 2 institutions. J Urol 1989; 142: 277–9.
[21] Goodwin WE, Casey WC, Woolf W. Percutaneous Trocar (needle) nephrostomy in hydronephrosis. JAMA 1955; 157: 891-894.
[22] Patel U, AbubackerMZ. Ureteral stent placement without postprocedural nephrostomy tube: experience in 41 patients. Radiology. 2004 Feb;230(2): 435-442.
[23] Sharma SD, Persad RA, Haq A, et al. A review of antegrade stenting in the management of obstructed kidney Br J Urol. 1996 Oct; 78(4): 511-515.
[24] Lu DS, Papanicolaou N, Girad M, et al. Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases. Clin Radiol. 1994 Apr; 49(4): 256-261.
[25] Venyo AK, Hanley T, Barrett M, Khan AN. Ante-grade ureteric stenting, retrospective experience in managing 89 patients: Indications, complications and outcome. Journal of biomedical graphics and computing. 2014 Aug 1;4(3):47.
[26] Jenkins CN, Marcus AJ. The value of antegrade stenting for lower ureteric obstruction. J R Soc Med. 1995 Aug; 86(8): 446-449.
[27] Borrell AP, Ferrer MP, Villamón RF, et al. Anterograde insertion of ureteral catheter. ActasUrol Esp. 2000 Mar; 24(3): 243-247.
[28] Farrell TA, Hicks ME. A review of radiologically guided percutaneous nephrostomies in 303 patients. J VascIntervRadiol 1997; 8: 769-774.
[29] Stables DP, Ginsburg NJ, Johnson MI. Percutaneous nephrostomy: a series and review of the literature. AJR Am J Roentgenol 1978; 130: 75-82.
[30] Pabon-Ramos WM, Dariushnia SR, Walker TG, et al. Society of Interventional Radiology Standards of Practice Committee. Quality Improvement Guidelines for Percutaneous Nephrostomy. J VascIntervRadiol 2016; 27:410–414.
[31] Kim BM, Park SI. Placement of double-J ureteric stent using the pull-through technique in patients with tight ureteric stents. Abdom Imaging. 2008 Mar-Apr; 33(2): 227-240.
[32] Carrafiello G, Lagana D, Lumia D, et al. Direct primary or secondary percutaneous ureteral stenting: what is the most compliant option in patients with malignant ureteral obstructions? Cardiovasc InterventRadiol. 2007 Sep 1; 30(5):974–80.